Laura M Skadsberg from Shoreview, MN, age 43

Laura Skadsberg Phones & Addresses

Shoreview, MN
Blaine, MN

Work

Company:

Medtronic
Sep 2017 to Apr 2019
Position:

Director, pre-market reliability engineering, af solutions

Education

Degree:

Masters
School / High School:

St. Cloud State University
2012 to 2013
Specialities:

Management, Engineering

Skills

Medical Devices • Design Control • Iso 13485 • Design of Experiments • Iso 14971 • Biomedical Engineering • Fda • Reliability Engineering • R&D • Capa • Fmea • Dmaic • V&V • Quality System • Failure Analysis • Design For Manufacturing • Minitab • Process Capability • Dfss • Biocompatibility

Industries

Medical Devices

Resumes

Quality Site Leader, Epix Af Solutions

view source

Location:

3315 Montgomery Dr, Santa Clara, CA 95054

Industry:

Medical Devices

Work:

Medtronic Sep 2017 - Apr 2019
Director, Pre-Market Reliability Engineering, Af Solutions
Medtronic Sep 2017 - Apr 2019
Quality Site Leader, Epix Af Solutions
Medtronic Apr 2016 - Sep 2017
Senior Released Product Reliability Engineering Manager, Af Solutions
Medtronic Jun 2009 - Apr 2012
Program Manager
Medtronic May 2006 - Jun 2011
Senior Reliability Engineer

Education:

St. Cloud State University 2012 - 2013
Masters, Management, Engineering University of Minnesota 2001 - 2005
Bachelors, Biomedical Engineering

Skills:

Medical Devices
Design Control
Iso 13485
Design of Experiments
Iso 14971
Biomedical Engineering
Fda
Reliability Engineering
R&D
Capa
Fmea
Dmaic
V&V
Quality System
Failure Analysis
Design For Manufacturing
Minitab
Process Capability
Dfss
Biocompatibility

Us Patents

Drug Elution For Implantable Incontinence Devices
view source
US Patent:

20060264697, Nov 23, 2006
Filed:

May 16, 2006
Appl. No.:

11/434966
Inventors:

Gerald Timm - Minneapolis MN, US
David Anderson - Brooklyn Park MN, US
Laura Skadsberg - Woodbury MN, US
Assignee:

GT UROLOGICAL, LLC. - MINNEAPOLIS MN
International Classification:

A61F 2/00
A61F 2/02
US Classification:

600029000, 600031000
Abstract:

An implantable incontinence device and method provides for occluding the urethra in preventing urine leakage. The device includes an occluding member connected to a control mechanism. The occluding member is movable from a contracted (occlusive) condition to an expansive (non-occlusive) condition by activating and deactivating the control mechanism. A drug coating is disposed on a portion of the implantable incontinence device. The drug coating elutes a bioaffecting or pharmaceutical composition to minimize capsular tissue formation, so that prevention of urine leakage can be facilitated.